Table 4.
Groups | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 |
---|---|---|---|---|---|---|---|---|---|---|
Cell-free + empty beads |
Human Myoblasts +empty beads |
USC+ empty beads |
USC/EC+ empty beads |
Cell free +all growth factor beads |
USC+ PDGF/HGF beads |
USC+ VEGF Beads |
USC+IGF/ FGF/NGF Beads |
USC+All growth factor containing beads |
USC/EC+All growth factor containing beads |
|
Gross measurement | ||||||||||
Graft size | 2+ | 3+˜4+ | 3+ | 3+ | 3+ | 4+ | 3+˜4+ | 4+ | 3+˜4+ | 4+ |
Blood supply | − | +˜2+ | 2+ | 2+ | 2+˜3+ | 3+ | 3+˜4+ | 2+˜3+ | 4+ | 4+ |
Cell density | ||||||||||
DAPI staining | + | 3+˜4+ | 2+˜3+ | 2+˜3+ | 2+ | 3+ | 4+ | 3+˜4+ | 4+ | 4+ |
Human nuclei staining | − | 3+ | 2+ | 2+˜3+ | − | 3+ | 3+˜4+ | 3+ | 3+˜4+ | 4+ |
Muscle regeneration | ||||||||||
MyoD | −˜+ | 3+˜4+ | 2+ | 2+ | 2+ | 3+˜4+ | 3+ | 2+˜3+ | 3+˜4+ | 4+ |
Desmin | − | 4+ | 2+ | +˜2+ | 2+ | 4+ | 2+˜3+ | 3+ | 4+ | 4+ |
Myf-5 | − | 4+ | +˜2+ | 2+ | 2+˜3+ | 3+ | 2+˜3+ | 2+ | 3+˜4+ | 4+ |
Angiogenesis | ||||||||||
Trichorome observation | + | 2+˜3+ | 2+ | 2+ | +˜2+ | 3+ | 3+˜4+ | 3+ | 4+ | 4+ |
CD 31 | −˜+ | 2+ | 2+˜3+ | 2+ | 2+˜3+ | 3+ | 3+˜4+ | 3+ | 3+˜4+ | 4+ |
vWF | −˜+ | +˜2+ | 2+ | 2+˜3+ | 2+˜3+ | 2+˜3+ | 3+ | 3+ | 4+ | 4+ |
Nerve regeneration | ||||||||||
S-100 | −˜+ | +˜2+ | +˜2+ | + | 2+ | +˜2+ | 2+ | 3+ | 4+ | 4+ |
NF | −˜+ | 2+ | 2+ | +˜2+ | 2+ | 2+ | 2+˜3+ | 3+˜4+ | 3+˜4+ | 4+ |
Notes: All growth factors including PDGF-BB/HGF/VEGF/IGF/FGF-1/NGF.
− no targeted cell or capillary; + 1%–25% of G10 changes; ++ 25%–50% of G10 changes; +++ 50%–75% of G10 changes; ++++ G10 changes as standard